Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;15(62):274-82.
doi: 10.15557/JoU.2015.0024. Epub 2015 Sep 30.

Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine

Affiliations

Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine

Andrzej Smereczyński et al. J Ultrason. 2015 Sep.

Abstract

Neuroendocrine tumors make up an interesting pathology of a variable clinical picture, prognosis, localization, endocrine activity and degree of malignancy.

Aim: The aim of this paper is to assess whether ultrasonography can be helpful in diagnosing neuroendocrine tumors in the small intestine by analyzing changes in the mesentery.

Material and methods: From 1996 to 2013, we encountered 17 patients (9 women and 8 men at the mean age of 57) with a neuroendocrine tumor in the small intestine. The diagnosis was confirmed in all patients by pathomorphological examinations. All retrospectively analyzed patients (n =17) had an abdominal US examination conducted in accordance with the previously mentioned protocol.

Results: Primary neuroendocrine tumors were visualized ultrasonography in 13 of 17 patients (76.5%). In the remaining 4 patients, tumors in the small bowel were diagnosed in CT enteroclysis (n = 3) and conventional enteroclysis (n = 1). Somatostatin receptor scintigraphy and CT enteroclysis supplemented the ultrasound result by providing information about the stage of the disease in 7 cases. In most of the 17 patients with a neuroendocrine tumor diagnosed by ultrasound (n = 11, 64.7%), changes in the mesentery were prevailing pathological signs that raised suspicion and, consequently, helped localize the primary lesion. The hypoechoic mesenteric lymph nodes were the greatest (9-18 mm), well-circumscribed, and the largest of them showed signs of vascularization. The size of hypoechoic lesions in the mesentery ranged from 25 to 53 mm. These lesions showed moderate blood flow. All of them were single, usually poorly circumscribed; two lesions showed slight calcifications.

Conclusions: In an abdominal US examination, 2/3 of patients with neuroendocrine tumors in the small bowel manifest secondary lesions in the mesentery which are easier to visualize than the primary focus. 30% of them are manifested as hypoechoic masses. The detection of such lesions should prompt the search for the primary focus in the small intestine.

Nowotwory neuroendokrynne to ciekawy dział patologii o zróżnicowanym obrazie klinicznym, rokowaniu, umiejscowieniu, czynności wydzielniczej i stopniu złośliwości.

Cel pracy: Celem pracy jest ocena możliwości diagnostyki nowotworów neuroendokrynnych jelita cienkiego przy użyciu ultrasonografii poprzez identyfikację zmian w krezce.

Materiał i metoda: W okresie od 1996 do 2013 roku zgromadzono 17 chorych (9 kobiet i 8 mężczyzn w średnim wieku 57 lat) z nowotworem neuroendokrynnym w jelicie cienkim. U wszystkich pacjentów potwierdzono rozpoznanie nowotworu neuroendokrynnego na podstawie badań patomorfologicznych. Wszystkie objęte retrospektywną analizą osoby (n = 17) miały wykonane badanie USG jamy brzusznej według protokołu opisanego wcześniej.

Wyniki: W badaniu ultrasonograficznym udało się uwidocznić pierwotny nowotwór neuroendokrynny u 13 z 17 chorych (76,5%). U pozostałych 4 osób guz zlokalizowany w jelicie cienkim został rozpoznany na podstawie enteroklizy TK (n = 3) i enteroklizy klasycznej (n = 1). Somatostatynowa scyntygrafia receptorowa i enterokliza TK dostarczyły dodatkowych informacji co do stopnia zaawansowania procesu chorobowego w stosunku do wyników badania USG w 7 przypadkach. Wśród 17 chorych z rozpoznanym ultrasonograficznie nowotworem neuroendokrynnym jelita cienkiego u większości (n = 11, 64,7%) zmiany w krezce jelita były dominującym objawem patologicznym, który pozwolił podejrzewać, a następnie zlokalizować zmianę pierwotną. Hipoechogeniczne węzły chłonne krezkowe miały największe wymiary (9–18 mm), były dobrze odgraniczone, a większe z nich wykazywały unaczynienie. Wielkość hipoechogenicznej masy w krezce wahała się od 25 do 53 mm. Zmiany tego typu wykazywały umiarkowane unaczynienie. Wszystkie były pojedyncze, przeważnie nieostro odgraniczone, a w dwóch zmianach obecne były niewielkie zwapnienia.

Wnioski: W badaniu USG przezbrzusznym u 2/3 chorych z guzem neuroendokrynnym w jelicie cienkim występują wtórne zmiany w krezce, które są łatwiejsze do zobrazowania niż samo ognisko pierwotne. W 30% manifestują się jako masy hipoechogeniczne. Wykrycie takich zmian powinno skłonić do poszukiwania ogniska pierwotnego w jelicie cienkim.

Keywords: abdominal ultrasound; diagnosis; mesenteric lesions; neuroendocrine tumors; small intestine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Metastatic lymph nodes (N) in the mesentery reflect the presence of a small intestinal carcinoid tumor (not shown in the figure)
Fig. 2
Fig. 2
One view shows irregular infiltration of a carcinoid tumor of the terminal ileum (C) and a sentinel lymph node (N)
Fig. 3
Fig. 3
Carcinoid tumor (12 mm) of the small bowel (not shown in the figure). In this case, an irregular hypoechoic and vascularized infiltration is visible in the mesentery
Fig. 4
Fig. 4
An irregular hypoechoic mass in the mesentery is the only manifestation of a carcinoid tumor in the ileum (not shown in the figure)
Fig. 5
Fig. 5
Two views of a hypoechoic mass (4 cm) in the mesentery of a 32-year-old patient with the body mass of 122 kg as the only ultrasound sign of a carcinoid tumor in the ileum
Fig. 6 A
Fig. 6 A
A sizeable, partially calcified hypoechoic mass (M) in the mesentery is a prominent manifestation of a carcinoid tumor in the ileum (not shown in the figure)
Fig. 6 B
Fig. 6 B
The same case. The vascularization of the lesion shown in a different view
Fig. 7 A
Fig. 7 A
One view captures a carcinoid tumor in the ileum (C) and a hypoechoic mass in the mesentery, which is greater than the primary lesion
Fig. 7 B
Fig. 7 B
The same patient. This view shows only the bean-shaped carcinoid tumor in the intestine, visualized with the use of a linear probe
Fig. 7 C
Fig. 7 C
The same patient, but the lesions are visualized in CT enteroclysis. The tumor of the terminal ileum (C) is of an identical shape to that visualized by ultrasonography. Moreover, two affected mesenteric lymph nodes are visible
Fig. 7 D
Fig. 7 D
The same patient. A different CT layer. It presents the mass (M) in the small intestine and two different affected mesenteric lymph nodes (n). Moreover, two metastatic foci were detected in the right lung (not shown here)
Fig. 8 A
Fig. 8 A
Carcinoid tumor (2 cm) of the ileum with features of hyperemia and with the markedly hyperechoic mesentery
Fig. 8 B
Fig. 8 B
The same patient. Dilated loops of the small intestine surrounding the thickened mesentery (M) indicate ileus
Fig. 9
Fig. 9
Thickened mesentery shows lesions that are difficult to visualize. They are an ultrasound representation of a carcinoid tumor in the small intestine (not shown in the figure)

Similar articles

Cited by

References

    1. Kos-Kudła B. Guzy neuroendokrynne przewodu pokarmowego; Gdańsk: Via Medica; 2010.
    1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959. - PubMed
    1. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117–122. - PMC - PubMed
    1. Modlin IM, Champoneria MC, Chan AK, Kidd M. A three-decade analysis 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol. 2007;102:1464–1473. - PubMed
    1. Yao JC, Hassan M, Phan A, Dagohoy C, Learg C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072. - PubMed

LinkOut - more resources